GROUP ONE TRADING, L.P. - NEUROBO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$04380.0%0.00%
Q1 2022$0
-100.0%
4380.0%0.00%
Q4 2021$1,000
-66.7%
438
-39.8%
0.00%
Q3 2021$3,000
-50.0%
728
-61.8%
0.00%
Q2 2021$6,0001,9040.00%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Mount Yale Investment Advisors, LLC 57,425$191,0000.02%
FNY Investment Advisers, LLC 10,000$33,0000.01%
SG3 Management, LLC 50,000$167,0000.01%
PITCAIRN CO 12,351$41,0000.00%
Ergoteles LLC 30,800$103,0000.00%
Advisory Services Network, LLC 8,550$28,0000.00%
HRT FINANCIAL LP 18,759$62,0000.00%
UBS Group AG 2,881$10,0000.00%
BANK OF AMERICA CORP /DE/ 1,062$4,0000.00%
WELLS FARGO & COMPANY/MN 320$1,0000.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders